Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.

Maksym, Jakub; Mazurek, Tomasz; Kochman, Janusz; Grygier, Marek; Kaplon-Cieslicka, Agnieszka; Marchel, Michal; Lodzinski, Piotr; Piatkowski, Radoslaw; Wilimski, Radoslaw; Czub, Pawel; Fojt, Anna; Karolczak, Natalia; Hendzel, Piotr; Opolski, Grzegorz

Maksym, Jakub; Mazurek, Tomasz; Kochman, Janusz; Grygier, Marek; Kaplon-Cieslicka, Agnieszka; Marchel, Michal; Lodzinski, Piotr; Piatkowski, Radoslaw; Wilimski, Radoslaw; Czub, Pawel; Fojt, Anna; Karolczak, Natalia; Hendzel, Piotr; Opolski, Grzegorz.

Affiliation

Mazurek T; 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland. tmazurek@kardia.pl.

Kardiol Pol ; 76(2): 459-463, 2018.

Article in En | MEDLINE | ID: mdl-29350390

Subject(s)

Aspirin/therapeutic use; Atrial Appendage/surgery; Atrial Fibrillation/surgery; Clopidogrel/therapeutic use; Aged; Aged, 80 and over; Aspirin/adverse effects; Atrial Fibrillation/complications; Clopidogrel/adverse effects; Drug Therapy, Combination; Female; Hemorrhage/chemically induced; Humans; Male; Patient Safety; Platelet Aggregation Inhibitors/adverse effects; Platelet Aggregation Inhibitors/therapeutic use; Stroke/etiology; Stroke/prevention & control; Treatment Outcome

Key words

atrial fibrillation; bleeding; dual antiplatelet therapy; left atrial appendage closure; stroke

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Atrial Fibrillation / Aspirin / Atrial Appendage / Clopidogrel Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Kardiol Pol Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google